Oncoustics raises $5.5m for ‘virtual biopsy’ AI platform
artificial intelligence, diagnosis, digital health, liver disease, Oncoustics, ultrasound
0 Comment
liver disease
FDA knocks back Mallinckrodt’s kidney drug terlipressin
kidney disease, liver disease, Mallinckrodt, regulatory, terlipressin
0 Comment
Mallinckrodt’s liver disease drug terlipressin edges FDA advisory panel
fda, kidney disease, liver disease, Mallinckrodt, rare disease, terlipressin
0 Comment
COVID-19 and vulnerable children: Urging caution while enjoying childhood
coronavirus, COVID-19, liver disease, primary sclerosing cholangitis, ulcerative colitis
0 Comment
Q&A: Novartis’ Eric Hughes on transplantation
kidney disease, liver disease, Novartis, transplantation
0 Comment
Novartis muscles into NASH fatty liver disease
hepatitis C, liver disease, NASH
0 Comment
Company’s Eric Hughes on what it takes to be leader in NASH – and what can be learnt from hepatitis C.